China holds roundtable with over 50 foreign pharmaceutical firms

Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.

The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.

Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.

You May Also Be Interested In

• SK Hynix said to price US listing at $149 per ADR
• Two Hands Corporation Confirms Completion of Voluntary Delisting from the Canadian Securities Exchange and Provides Update on Quantum-Focused Corporate Name Change
• The First AEO-Certified PR Agency Trustpoint Xposure Targets New York Law Firms, Guaranteeing Attorneys Appear in AI-Generated Legal Recommendations Before Competitors Claim the Position